SummaryHavila Kystruten delivered further improvements in both revenue and profitability in the first quarter of 2025. The company reported a strengthened operating result (EBITDA), primarily driven by top-line growth. In Q1 2025, Havila Kystruten generated revenues of MNOK 350, an increase of 20% from MNOK 293 in the same period last year. The growth was mainly due to a 35% increase in average cabin revenue (ACR), which rose from NOK 3,350 to NOK 4,600. Onboard sales per guest night remained stable compare ...

The board of directors of Havila Kystruten AS has today approved the financial statements and annual report for 2024, which integrates financial and sustainability reporting. The report is attached in PDF format. It summarizes the year and highlights the company's fundamental focus on the environment and sustainability. Contacts:Chief Executive Officer: Bent Martini, +47 905 99 650Chief Financial Officer: Aleksander Røynesdal, +47 413 18 114 This information is subject to the disclosure requirements pursu ...

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) announces that it has granted an additional 633,589 restricted share units (“RSUs”) and 330,132 stock options (“Options”) to continuing employees and consultants of Rocket Doctor Inc., the Company’s wholly-owned subsidiary (see News Release dated April 10, 2025). The ...

MARKHAM, Ontario, May 27, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today announced the results of matters voted on at its annual and special meeting of shareholders held on May 27, 2025 (the “Meeting”). The voting results for each of the matters considered at the Meeting are presented below. The total number of common shares represented by shareholders present in person or by proxy at the Meeting was 47,282,730, representing 56.41% of the Company’s outstanding c ...

Core Viewpoint - Teva Pharmaceutical Industries has received Fast Track designation from the FDA for its investigational anti-IL-15 antibody, TEV-53408, aimed at treating celiac disease, highlighting the urgent need for effective treatments in this area [1][3][7]. Company Overview - Teva Pharmaceutical Industries Ltd. is a global biopharmaceutical leader with over 120 years of experience, focusing on innovation and the development of medicines, including generics and biologics, to improve health outcomes [6]. Product Development - TEV-53408 is currently undergoing a Phase 2a trial to evaluate its efficacy and safety in adults with celiac disease, which affects approximately 1% of the global population [1][4][5]. - The drug works by inhibiting interleukin-15 (IL-15), which is responsible for the immune response to gluten, thereby aiming to reduce intestinal inflammation and damage in celiac disease patients [3][4]. Market Need - Celiac disease is a chronic autoimmune disorder that significantly impacts quality of life, with the only current treatment being a strict gluten-free diet, which many patients struggle to adhere to [5]. - There is a significant unmet medical need for new treatment options, as many patients continue to experience debilitating symptoms even on a gluten-free diet [3][5].

TORONTO, May 27, 2025 (GLOBE NEWSWIRE) -- Captor Capital Corp. (“Captor” or the “Company”) (CSE: CPTR) is excited to announce a significant milestone in its growth strategy with the acquisition of US$500,000 in Bitcoin for treasury holdings and the issuance of unsecured convertible loan notes (the “Notes”) in the aggregate amount of US$450,000 to a European-based institutional investor (the “Noteholder”). These strategic moves reinforce Captor’s commitment to innovative financial strategies and delivering e ...

Net Income Increased by 17.3% Compared to Q1/2024CALGARY, Alberta, May 27, 2025 (GLOBE NEWSWIRE) -- Tornado Infrastructure Equipment Ltd. (“Tornado” or the “Company”) (TSX-V: TGH; OTCQX: TGHLF) today reported its unaudited condensed consolidated financial results for the three months period ended March 31, 2025. The unaudited condensed consolidated financial statements and related management discussion and analysis are available on the Company’s issuer profile in Canada on SEDAR+ at www.sedarplus.com, in th ...

Monterey, CA , May 27, 2025 (GLOBE NEWSWIRE) -- ChampionsGate Acquisition Corporation (Nasdaq: CHPGU) (the “Company”) announced today the pricing of its initial public offering of 6,500,000 units at $10.00 per unit. The units are expected to be listed on the Nasdaq Global Market (“Nasdaq”) and trade under the ticker symbol “CHPGU” beginning May 28, 2025. Each unit consists of one Class A ordinary share and one right to receive one-eighth of one Class A ordinary share. Once the securities comprising the unit ...

Core Viewpoint - Northrop Grumman Corporation has announced a $1.0 billion public offering of senior unsecured notes, aimed at general corporate purposes including debt repayment, share repurchases, and working capital [1]. Group 1: Offering Details - The offering consists of $500 million of 4.650% senior notes due 2030 and $500 million of 5.250% senior notes due 2035 [6]. - The expected closing date for the offering is May 29, 2025, pending customary closing conditions [1]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized for general corporate purposes, which may include repayment of existing senior notes with interest rates of 7.875% and 7.750% due in 2026 [1].

VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) -- DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB US: DMGGF) (FRANKFURT: 6AX) (“DMG” or the “Company”), a vertically integrated data center and digital asset technology company, announces that DMG’s digital asset custody subsidiary, Systemic Trust Company (“STC”) has added the capability to send bitcoin in a regulatory compliant and carbon neutral manner. This enablement is the keystone that bridges the key pillars of DMG’s carbon-neutral Bitcoi ...